Correlation Between VentriPoint Diagnostics and Bluejay Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and Bluejay Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and Bluejay Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VentriPoint Diagnostics and Bluejay Diagnostics, you can compare the effects of market volatilities on VentriPoint Diagnostics and Bluejay Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of Bluejay Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and Bluejay Diagnostics.

Diversification Opportunities for VentriPoint Diagnostics and Bluejay Diagnostics

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between VentriPoint and Bluejay is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and Bluejay Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluejay Diagnostics and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with Bluejay Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluejay Diagnostics has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and Bluejay Diagnostics go up and down completely randomly.

Pair Corralation between VentriPoint Diagnostics and Bluejay Diagnostics

Assuming the 90 days horizon VentriPoint Diagnostics is expected to under-perform the Bluejay Diagnostics. But the otc stock apears to be less risky and, when comparing its historical volatility, VentriPoint Diagnostics is 4.14 times less risky than Bluejay Diagnostics. The otc stock trades about -0.05 of its potential returns per unit of risk. The Bluejay Diagnostics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  530.00  in Bluejay Diagnostics on August 28, 2024 and sell it today you would lose (155.00) from holding Bluejay Diagnostics or give up 29.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

VentriPoint Diagnostics  vs.  Bluejay Diagnostics

 Performance 
       Timeline  
VentriPoint Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Bluejay Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

VentriPoint Diagnostics and Bluejay Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VentriPoint Diagnostics and Bluejay Diagnostics

The main advantage of trading using opposite VentriPoint Diagnostics and Bluejay Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, Bluejay Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluejay Diagnostics will offset losses from the drop in Bluejay Diagnostics' long position.
The idea behind VentriPoint Diagnostics and Bluejay Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world